Pharmaceutical composition for treating esophageal achalasia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
Achalasia and composition technology, applied in the field of traditional Chinese medicine, can solve the problems of patients with great pain, high recurrence rate, and poor compliance, and achieve the effects of relieving clinical symptoms, strong dispersing ability, and improving poor coordination of relaxation and relaxation
Inactive Publication Date: 2013-07-10
朱明莉
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, the clinical curative effect of the above-mentioned drugs is below 50%, and more patients have to undergo surgical treatment. The less invasive method is endoscopic balloon dilation, but dilation often requires multiple times to achieve remission, and the recurrence rate is high. Great pain and poor compliance
Therefore, there is currently a lack of a clinically effective medical treatment drug for esophageal achalasia
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0028] Example 1, the weight ratio of raw materials: Muhe 20g, Usnea 10g, Poria cocos 6g, Tangerine peel 10g, Artemisia annua root 6g, Trichonia vine 10g, Pueraria lobata 10g, Aescin 10g, loofah 12g, Jiulixiang 2g , burnt malt 6g, burnt grain sprouts 20g.
[0029] The preparation method of Example 1 is: mix and decoct Muhe, Usnea, Poria, Tangerine Peel, Artemisia annua Root, Caterpillar, Pueraria, Aescin, Loofah, Gurixiang, Scorched Malt, and Scorched Valley Buds in water for 30 After 2 minutes, take the filtrate, add water to the dregs and continue to decoct for 20 minutes, then take the filtrate, combine the two filtrates, divide it into two parts and take it in the morning and evening.
Embodiment 2
[0030] Example 2, weight ratio of raw materials: 10 parts of Muhe, 6 parts of Usnea, 3 parts of Poria cocos, 6 parts of dried tangerine peel, 3 parts of Artemisia annua root, 6 parts of Poria vine, 6 parts of Pueraria lobata, 6 parts of Aescin , 6 parts of loofah, 1 part of Jiulixiang, 3 parts of burnt malt, and 10 parts of burnt grain sprouts.
Embodiment 3
[0031] Example 3, the weight ratio of raw materials: 20 parts of Muhe, 10 parts of Usnea, 6 parts of Poria cocos, 10 parts of dried tangerine peel, 6 parts of Artemisia annua root, 10 parts of terrazzo vine, 10 parts of kudzu root, 10 parts of Aescin , 10 parts of loofah, 2 parts of Jiulixiang, 6 parts of burnt malt, and 20 parts of burnt grain sprouts.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for treating esophageal achalasia. The pharmaceutical composition is applied to the treatment of esophageal achalasia. The pharmaceutical composition is characterized by being prepared from the following raw pharmaceutical materials in proportioning ratio by weight: fingerleaf rodgersflower rhizome, usnea diffracta Vain., poriacocos (Schw.) Wolf, luffa cylindrica (L.) Roem., murraya jasminorage, hordeum vulgare L., setaria italica (L.) Beauv., citrus reticulata Blanco, artemisia japonica Thunb., trachelospermum jasminoides (Lindl.) Lem., radix puerariae and paris polyphylla Sm.. Proved by clinical trials, the pharmaceutical composition has the characteristics of good treatment effect and high safety in the treatment of esophageal achalasia, so that the pharmaceutical composition is worthy of clinical application and popularization.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating esophageal achalasia. Background technique [0002] Esophageal achalasia is a primary total esophageal motility disorder characterized by ① no peristalsis in the esophageal body. ② When swallowing, the lower esophageal sphincter does not relax or does not relax completely. ③The lower esophageal sphincter pressure increases at rest. Although achalasia is a benign disease, it has a great impact on quality of life, health and longevity. Due to dysphagia, patients can use all measures, including body position, drinking water, repeated swallowing and other measures, so that patients are ashamed to eat in front of everyone and prefer to eat alone, causing psychological pressure and seriously affecting social activities. The cause of this disease is unknown. It may be related to toxins, nutritional deficiencies, genes and local in...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more